163 related articles for article (PubMed ID: 3610337)
21. Effect of intratracheal gallium arsenide administration on delta-aminolevulinic acid dehydratase in rats: relationship to urinary excretion of aminolevulinic acid.
Goering PL; Maronpot RR; Fowler BA
Toxicol Appl Pharmacol; 1988 Feb; 92(2):179-93. PubMed ID: 3341032
[TBL] [Abstract][Full Text] [Related]
22. [Use of some indicators of "effect" in subjects exposed to lead].
Abbritti G
Med Lav; 1978; 69(1):96-7. PubMed ID: 651778
[No Abstract] [Full Text] [Related]
23. Clinical relevance of urinary delta-aminolevulinic acid/logarithm of creatinine ratio in screening for occupational lead exposure.
Hudák A; Náray M; Süveges E
Am J Ind Med; 1992; 21(5):673-80. PubMed ID: 1609813
[TBL] [Abstract][Full Text] [Related]
24. Urinary delta-aminolevulinic acid as a biological indicator throughout penicillamine therapy in lead intoxication.
Molina-Ballesteros G; Zuñiga-Charles MA; Sanchez-Anzaldo FJ; Gonzalez-Ramirez JD
Arch Environ Health; 1978; 33(6):308-13. PubMed ID: 736614
[TBL] [Abstract][Full Text] [Related]
25. [Lead level in taxi drivers as characterized by the urinary excretion of delta aminolevulinic acid. 1. Report on lead poisoning preventive measures in the Vienna area in various occupational and other groups].
Maruna RF; Maruna H
Wien Med Wochenschr; 1975 Oct; 125(42-44):615-20. PubMed ID: 58483
[No Abstract] [Full Text] [Related]
26. [Biological monitoring of workers exposed to lead. Usefulness and limitations of indicators of internal dose and early biological effect].
Alessio L; Bertazzi PA; Cortona G
Med Lav; 1978; 69(1):4-25. PubMed ID: 349336
[No Abstract] [Full Text] [Related]
27. A chronobiological study of delta-amino levulinic acid urinary excretion.
Botta A; Bruguerolle B; Bartolin R; Bouvenot G
Chronobiol Int; 1987; 4(4):509-12. PubMed ID: 3435928
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of some parameters of lead exposure and possible correlation between them.
Soliman MH; El-Sadek YM; El-Kashlan KM; Gabr Y; El-Waseef A
J Egypt Med Assoc; 1976; 59(5-6):469-80. PubMed ID: 1032315
[No Abstract] [Full Text] [Related]
29. [Experience with the Grabecki and co-workers method of urinary delta-aminolevulinic acid determination in the prevention of lead intoxication].
Müller W; Holzapfel G
Int Arch Arbeitsmed; 1969 Dec; 25(4):287-91. PubMed ID: 5370813
[No Abstract] [Full Text] [Related]
30. Urinary delta-aminolevulinic acid (ALA) excretion in humans and cattle as an index of exposure to lead.
Adaudi AO; Aliu YO
Vet Hum Toxicol; 1980 Dec; 22(6):403-5. PubMed ID: 7210469
[TBL] [Abstract][Full Text] [Related]
31. [Determination of delta-aminolevulinic acid dehydratase in venous and capillary blood and delta-aminolevulinic acid in urine of lead-exposed workers].
Rothe R; Garlipp C
Arch Exp Veterinarmed; 1980; 34(3):361-5. PubMed ID: 7436670
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of initial results of treatment of lead poisoning with EDTA].
Petkova V; Adjarov D; Pavlova S; Naydenova E; Kerimova M; Kuneva T
Med Lav; 1994; 85(4):299-308. PubMed ID: 7808345
[TBL] [Abstract][Full Text] [Related]
33. Optimized fluorometric determination of urinary delta-aminolevulinic acid by using pre-column derivatization, and identification of the derivative.
Okayama A; Fujii S; Miura R
Clin Chem; 1990 Aug; 36(8 Pt 1):1494-7. PubMed ID: 2103726
[TBL] [Abstract][Full Text] [Related]
34. [Significance of urinary delta-aminolevulinic acid determination in the evaluation of individual exposure to lead].
Sartor F; Rondia D
Arch Belg Med Soc; 1978 May; 36(5):283-95. PubMed ID: 736553
[No Abstract] [Full Text] [Related]
35. Delta-aminolevulinic acid dehydratase (ALAD) polymorphism in lead exposed Bangladeshi children and its effect on urinary aminolevulinic acid (ALA).
Tasmin S; Furusawa H; Ahmad SA; Faruquee MH; Watanabe C
Environ Res; 2015 Jan; 136():318-23. PubMed ID: 25460652
[TBL] [Abstract][Full Text] [Related]
36. Comparison of colorimetric and HPLC methods for determination of delta-aminolevulinic acid in urine with reference to dose-response relationship in occupational exposure to lead.
Fukui Y; Miki M; Ukai H; Okamoto S; Takada S; Ikeda M
Ind Health; 2005 Oct; 43(4):691-8. PubMed ID: 16294925
[TBL] [Abstract][Full Text] [Related]
37. Environmental lead exposure and activity of delta-aminolevulinic acid dehydratase (ALA-D) in maternal and cord blood.
Campagna D; Huel G; Girard F; Sahuquillo J; Blot P
Toxicology; 1999 Jun; 134(2-3):143-52. PubMed ID: 10403633
[TBL] [Abstract][Full Text] [Related]
38. [Determination of urinary delta-aminolevulinic acid using a descrete automatized analyzer].
Cavalleri A; Bianco L; Biscaldi GP
Med Lav; 1976; 67(2):145-51. PubMed ID: 1021707
[No Abstract] [Full Text] [Related]
39. Effects of perinatal treatment with lead and disulfiram on ALAD activity in blood, liver and kidney and urinary ALA excretion in rats.
Oskarsson A
Pharmacol Toxicol; 1989 Apr; 64(4):344-8. PubMed ID: 2748540
[TBL] [Abstract][Full Text] [Related]
40. [Study on relationships between biomarkers in workers with low-level occupational lead exposure].
Yang H; Zhang H; Zhou Q; Gong W; Zhu B; Li W; Zhou Y
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2015 Jun; 33(6):403-8. PubMed ID: 26653370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
